Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-NS-22-067

Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection- Interventions from Small Businesses (U44 Clinical Trial Not Allowed)

Closed on July 28, 2022.

Posted
May 24, 2022
Close date
July 28, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $299,550 in first-year total cost, median $299,550.

Most frequent study sections

  1. Special Emphasis Panel[ZNS1 SRB-D (24)]1

Most frequent institutions

  1. NEUREXIS THERAPEUTICS, INC.1
Competing awards under RFA-NS-22-067 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Comparative testing of tatCN19o for neuroprotection in rodent tMCAo1U44NS132339-01ASFAHA, OLIVIA RUTHGOFORTH, ROBYN LNEUREXIS THERAPEUTICS, INC., CO$299,550ZNS1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CVHow the NIH biosketch works
RFA-NS-22-067: Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection- Interventions from Small Businesses (U44 Clinical Trial Not Allowed) | ScienceDex | ConductScience